[PDF][PDF] Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal caricinoma: docetaxal plus carboplatin …
X Lu, X Guo, MH Hong, QY Chen, Q Zeng… - Chin J …, 2010 - scholar.archive.org
Chinese Journal of Cancer adenocarcinoma; those aged> 60 or< 18 years; KPS score< 80;
abnormal liver and kidney functions; heart disease or impaired heart function; those who …
abnormal liver and kidney functions; heart disease or impaired heart function; those who …
Treatment of advanced squamous cell caricinomas of the head and neck with initial combination chemotheraphy prior to surgery and/or radiotheraphy: five-year …
HJ Shaw, LA Price, BT Hill - The Journal of Laryngology & Otology, 1984 - cambridge.org
One hundred and thirty-nine patients with advanced head and neck cancer were treated
with a combination of vincristine, bleomycin, methotrexate with a folinic acid rescue, 5 …
with a combination of vincristine, bleomycin, methotrexate with a folinic acid rescue, 5 …
An open, multicenter clinical study on cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in nasopharyngeal carcinoma …
T Lu, C Zhao, C Chen, L Gao, J Lang, J Pan… - Journal of Clinical …, 2010 - ascopubs.org
5577 Background: To evaluate the safety and efficacy of cetuximab combined with IMRT+
concurrent cisplatin chemotherapy in patients with loco-regionally advanced NPC in a …
concurrent cisplatin chemotherapy in patients with loco-regionally advanced NPC in a …
Cetuximab in combination with chemoradiation after induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma: preliminary results
X He, J Xu, W Guo, X Jiang, X Wang, D Zong - Future oncology, 2013 - Taylor & Francis
Aim: This article aimed to determine treatment compliance, acute toxicities and the short-
term curative effects of combining cetuximab with chemoradiation following induction …
term curative effects of combining cetuximab with chemoradiation following induction …
An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally …
C Chen, C Zhao, L Gao, J Lang, J Pan, C Hu, F Jin… - 2012 - ascopubs.org
5535 Background: To evaluate the safety and efficacy outcomes of concurrent cetuximab
plus IMRT and cisplatin in Chinese patients with LA NPC. Methods: Patients with primary …
plus IMRT and cisplatin in Chinese patients with LA NPC. Methods: Patients with primary …
Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a propensity score analysis
WX Xia, H Liang, X Lv, L Wang, CN Qian, YF Ye, LR Ke… - Oral Oncology, 2017 - Elsevier
Objective To compare the effectiveness of concurrent cisplatin chemoradiotherapy plus
cetuximab with that of concurrent chemoradiotherapy (CCRT) alone in locoregionally …
cetuximab with that of concurrent chemoradiotherapy (CCRT) alone in locoregionally …
Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin+ taxol in locally advanced nasopharyngeal carcinoma
M Airoldi, P Gabriele, AM Gabriele, M Garzaro… - Cancer chemotherapy …, 2011 - Springer
Purpose Aim of this study was the clinical evaluation of carboplatin–taxol combination in a
neoadjuvant and concomitant setting with conventional radiotherapy in loco-regionally …
neoadjuvant and concomitant setting with conventional radiotherapy in loco-regionally …
[HTML][HTML] Phase II study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal …
Y Wu, X Wei, Z Yuan, H Xu, Y Li, Y Li, L Hu… - Chinese Journal of …, 2020 - ncbi.nlm.nih.gov
Objective For locally advanced nasopharyngeal carcinoma (LA-NPC) patients, high
incidences of distant metastases and severe treatment related toxicities are the main …
incidences of distant metastases and severe treatment related toxicities are the main …
[HTML][HTML] A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
Background Based on our previous work on the clinical activity of cetuximab in recurrent
nasopharyngeal carcinoma (NPC), we evaluated the feasibility of adding cetuximab to …
nasopharyngeal carcinoma (NPC), we evaluated the feasibility of adding cetuximab to …
Carboplatin plus taxol is an effective third-line regimen in recurrent undifferentiated nasopharyngeal carcinoma
M Airoldi, F Pedani, S Marchionatti… - Tumori …, 2002 - journals.sagepub.com
Background Recurrent undifferentiated nasopharyngeal carcinoma is a chemosensitive
disease. Few third-line treatments have been reported. Methods Twelve patients (9 males, 3 …
disease. Few third-line treatments have been reported. Methods Twelve patients (9 males, 3 …